Company Performance - Block reported quarterly earnings of $0.56 per share, missing the Zacks Consensus Estimate of $0.88 per share, and down from $0.85 per share a year ago, representing an earnings surprise of -36.36% [1] - The company posted revenues of $5.77 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 6.65%, and down from $5.96 billion year-over-year [2] - Over the last four quarters, Block has surpassed consensus EPS estimates just once and has not beaten consensus revenue estimates [2] Stock Performance - Block shares have lost about 31.2% since the beginning of the year, compared to the S&P 500's decline of -5.3% [3] - The current status of estimate revisions for Block is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $1 on $6.59 billion in revenues, and $4.12 on $26.06 billion in revenues for the current fiscal year [7] - The outlook for the industry can significantly impact the stock's performance, with the Internet - Software industry currently in the bottom 43% of Zacks industries [8]

Company Performance - iRhythm Technologies reported a quarterly loss of $0.95 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.89, but an improvement from a loss of $1.47 per share a year ago, indicating a year-over-year improvement [1] - The company posted revenues of $158.68 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.34% and showing an increase from $131.93 million in the same quarter last year [2] - Over the last four quarters, iRhythm Technologies has exceeded consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - iRhythm Technologies shares have increased by approximately 18.5% since the beginning of the year, contrasting with a decline of 5.3% in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.55 on revenues of $171.04 million, and for the current fiscal year, it is -$1.75 on revenues of $681.28 million [7] Industry Outlook - The Medical Info Systems industry, to which iRhythm Technologies belongs, is currently ranked in the top 18% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - The performance of iRhythm Technologies' stock may be influenced by the overall industry outlook, as empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions [5][8]

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Diebold Nixdorf, Incorporated (DBD) .Diebold Nixdorf, Incorporated currently has an average bro ...

Core Viewpoint - Stagwell (STGW) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - For Stagwell, the increase in earnings estimates and the rating upgrade suggest an improvement in the company's underlying business, likely leading to a rise in stock price [5][10]. Earnings Estimate Revisions - Stagwell is projected to earn $0.86 per share for the fiscal year ending December 2025, reflecting a year-over-year increase of 11.7% [8]. - Over the past three months, the Zacks Consensus Estimate for Stagwell has risen by 3.6%, indicating a positive trend in analyst expectations [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with only the top 20% receiving a 'Strong Buy' or 'Buy' rating, highlighting their potential for superior returns [9][10]. - Stagwell's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a favorable outlook for near-term stock performance [10].

Group 1 - Adherex Technologies Inc. (FENC) closed at $6.19, with an 11.9% gain over the past four weeks, and a mean price target of $13.20 suggests an upside potential of 113.3% [1] - The mean estimate includes five short-term price targets with a standard deviation of $2.05, indicating variability among analysts; the lowest estimate of $10 suggests a 61.6% increase, while the highest estimate of $15 indicates a 142.3% increase [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 134.6% over the past month [11][12] Group 2 - FENC holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential upside in the near term [13] - While price targets are often viewed as a key metric, they can mislead investors; analysts may set overly optimistic targets due to business incentives, which can inflate expectations [7][8] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement direction, serving as a starting point for further research [9]

Shares of Comfort Systems (FIX) have gained 20.5% over the past four weeks to close the last trading session at $397.54, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $512.60 indicates a potential upside of 28.9%.The mean estimate comprises five short-term price targets with a standard deviation of $48.99. While the lowest estimate of $465 indicates a 17% increase from the cur ...

Tarsus Pharmaceuticals, Inc. (TARS) closed the last trading session at $50.90, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $67.13 indicates a 31.9% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $13.74. While the lowest estimate of $41 indicates a 19.5% decline from the current price level, the most optimist ...

Investors might want to bet on TripAdvisor (TRIP) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing e ...

Group 1 - First Community (FCCO) shares have increased by 5.1% over the past four weeks, closing at $23.70, with a mean price target of $29.67 indicating a potential upside of 25.2% [1] - The average price targets range from a low of $29 to a high of $30, with a standard deviation of $0.58, suggesting a relatively high agreement among analysts [2] - Analysts are optimistic about FCCO's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has historically correlated with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1.1% over the past month, with one estimate rising and no negative revisions [12] - FCCO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Shares of FormFactor (FORM) have gained 0.9% over the past four weeks to close the last trading session at $28.54, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $42 indicates a potential upside of 47.2%.The average comprises nine short-term price targets ranging from a low of $26 to a high of $52, with a standard deviation of $8.83. While the lowest estimate indicates a declin ...